Gaohua Lu, Ph.D., Bristol Myers Squibb
personal info
Gaohua Lu is a Senior Director at BMS in the USA, where he leads the PBPK group in the Clinical Pharmacology and Pharmacometrics (CPP) department. Over the past three years, Gaohua has demonstrated exceptional leadership, significantly enhancing the PBPK group’s capabilities to support drug discovery and development across all phases, including FTIH, DDI, special populations, biopharmaceutics (FE/ARA, particle size, excipients, and biowaiver), biologics, and new therapeutic modalities.
With an engineering background and a Ph.D. from Tokyo Medical & Dental University in 2004, Gaohua brings a wealth of expertise to his role. Prior to joining BMS, Gaohua held positions at RIKEN (2004-2010), Simcyp (2010-2017), and GSK (2017-2020), where he contributed significantly to various aspects of translational PBPK, quantitative clinical pharmacology and pharmacometrics.
Throughout his career, Gaohua has been instrumental in driving innovation and achieving notable milestones in the field. His dedication to advancing pharmaceutical science has been evident in his leadership roles and collaborative efforts within multidisciplinary teams.